Young Adult Insulin Resistance Predicts Midlife Cardiovascular Disease Risk
Insulin resistance in young adulthood serves as a predictor of atherosclerotic cardiovascular disease years down the line in middle age, according to a CARDIA cohort analysis published by MedPage Today.
Researchers examined more than 3,000 CARDIA participants who remained under observation and free of atherosclerotic cardiovascular disease through year 20 when they were 38 to 50 years old, with one in four showing insulin resistance at baseline at age 18 to 30. Chuyue Wu, MD, PhD, of the UCLA Fielding School of Public Health in Los Angeles led the reporting group, according to MedPage Today.
Individuals with insulin resistance in early adulthood faced a higher risk of atherosclerotic cardiovascular disease events through year 35 of the study when they were 53 to 65 years old, yielding a risk ratio of 1.50 with a 95% confidence interval of 1.13 to 2.01.
“These findings have potential implications for early cardiovascular prevention by suggesting that IR in young adulthood may signal an adverse CKM trajectory before conventional cardiometabolic risk factors become fully established,” Wu and colleagues wrote in JACC: Advances, as cited by MedPage Today.
Midlife Metabolic Syndrome Mediates Long-Term Cardiovascular Risk
Researchers discovered that 63.4% of the relationship between early insulin resistance and later atherosclerotic cardiovascular disease was mediated by midlife metabolic syndrome at the year-20 mark, producing an indirect risk ratio of 1.29 with a 95% confidence interval of 1.13 to 1.48.

Fasting insulin is not routinely measured in clinical practice. Investigators indirectly measured insulin resistance as a Homeostatic Model Assessment of Insulin Resistance value at or above the 75th percentile of 2.67 or greater after a 12-hour fast, which may not exactly match the gold-standard hyperinsulinemic-euglycemic clamp method.
“The substantial mediation through midlife MetS further identifies the clustering of abnormalities in adiposity, blood pressure, glucose, and lipids as a potentially important intermediate stage linking early IR to later ASCVD,” Wu’s group suggested, according to MedPage Today.
The study utilized data from 3,622 participants enrolled in 1985 and 1986 as young adults with a mean baseline age of 25.0 years, comprising 45% men and 47% Black individuals who remained free of atherosclerotic cardiovascular disease through year 20. Metabolic syndrome criteria required meeting three measures including waist circumference of 102 cm or greater in men or 88 cm or greater in women, and triglycerides of 150 mg/dL or higher.
Urgency Required in Clinical Practice Settings
An accompanying editorial by Amier Haidar, MD, MPH, of McGovern Medical School at the University of Texas Health Science Center at Houston, and Leonardo Roever, MHS, PhD, of the Brazilian Evidence-Based Health Network in Uberlândia, Brazil, offered perspective on the findings.
“For current practice, the most important implication is therefore not a new laboratory test. It is a new sense of urgency,” Haidar and Roever stressed, as reported by MedPage Today.
“A young adult with progressively increasing abdominal adiposity, worsening blood pressure, rising triglycerides, and deteriorating glycemic measures should not need to accumulate multiple abnormalities before clinicians recognize the direction of travel,” the editorial duo said.
“Young adulthood represents a particularly important and underused window for prevention. Young adulthood is therefore not a cardiovascular waiting room; it is a period when cardiometabolic trajectories are being established,” they added in findings carried by MedPage Today.
Study authors acknowledged that they did not account for changes in metabolic syndrome status and individual components before or after year 20, and residual confounding remains possible due to the observational nature of the research. Further investigation is required to determine whether Homeostatic Model Assessment of Insulin Resistance improves risk prediction beyond standard clinical factors and whether preventing progression to metabolic syndrome reduces subsequent cardiovascular events.
The UCLA Fielding School of Public Health was founded in 1961 and currently operates out of the Center for Health Sciences building on the university’s Westwood campus. Home to nearly 1,000 students representing 25 countries, the institution maintains five academic departments and offers a wide range of graduate degrees.
The school reached a significant turning point in 2012 when it received a $50 million gift from the Fielding family, marking the largest single donation in its history and resulting in the school’s current official naming. Today, it remains an active hub for research across various disciplines, including epidemiology and health policy.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.